PATENT CLAIM ANALYSIS

Application Number: 16423362
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "249000"]

Abstract:
The invention provides compounds effective as inhibitors of monocarboxylate transporters such as MCT1 and MCT4, which can be used for treatment of medical conditions wherein treatment of the condition with a compound having an inhibitor effect on MCT1, MCT4, or both is medically indicated. Compounds of the invention can have antitumor, antidiabetes, anti-inflammatory, or immunosuppressive pharmacological effects, and can be effective for treatment of cancer and of type II diabetes.

Claim (Index 3):
The compound of  claim 1 , wherein a bicyclic R 3  is any one of wherein X is H, (C 1 -C 6 )alkyl, or CF 3 ; and\n wherein Y is optionally present and, when present, Y is 1-3 instances of a substituent selected from the group consisting of F, Cl, Br, CF 3 , CH 3 , Et, NH 2 , NH\u2014(CH 2 ) j \u2014CH 2 -Q, and \n wherein j=2-6, and wherein Q is one of the following groups wherein a wavy line indicates a point of bonding, and wherein Y can be disposed on any ring of a multi-ring system.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 100.0
- Lexical Diversity: 1.51923
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15545152', '15545168', '15545117', '15575037', '09881913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7974092352935024
- 35 USC 102 Novelty (BERT): 0.6497561016054533
- Combined Prediction Score: 0.7826439219246974
- Mean Citation Score: 407.02444
- Max Citation Score: 602.3753
- Similarity Product: 597.3774840924383

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test